Rac1b recruits dishevelled and β-catenin to Wnt target gene promoters independent of Wnt3A stimulation

International Journal of Oncology

Volumn 39, Issue 4, 2011, Pages 805-810

  Pethe, Vaijayanti V ^a   Charames, George S ^a,b   Bapat, Bharati ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Colon cancer; Rac1b; Wnt signaling

Indexed keywords

BETA CATENIN; CYCLIN D1; DISHEVELLED PROTEIN; GUANOSINE TRIPHOSPHATASE; MYC PROTEIN; RAC1 PROTEIN; RAC1B PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3A PROTEIN;

ARTICLE; CARCINOGENESIS; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE ACTIVATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BETA CATENIN; BINDING SITES; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CYCLIN D1; GENES, MYC; HCT116 CELLS; HEK293 CELLS; HUMANS; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WNT3A PROTEIN;

EID: 79960865336     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1066     Document Type: Article

References (28)

1. Price LS and Collard JG: Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion. Semin Cancer Biol 11: 167-173, 2001. (Pubitemid 32423291)
2. Lozano E, Betson M and Braga VM: Tumor progression: small GTPases and loss of cell-cell adhesion. Bioessays 25: 452-463, 2003. (Pubitemid 36565683)
3. Mertens AE, Roovers RC and Collard JG: Regulation of Tiam1-Rac signalling. FEBS Lett 546: 11-16, 2003. (Pubitemid 36782277)
4. Jordan P, Brazao R, Boavida MG, Gespach C and Chastre E: Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 18: 6835-6839, 1999.
5. Singh A, Karnoub AE, Palmby TR, Lengyel E, Sondek J and Der CJ: Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene 23: 9369-9380, 2004. (Pubitemid 40069669)
6. Schnelzer A, Prechtel D, Knaus U, et al: Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19: 3013-3020, 2000. (Pubitemid 30389092)
7. Matos P, Collard JG and Jordan P: Tumor-related alternatively spliced Rac1b is not regulated by Rho-GDP dissociation inhibitors and exhibits selective downstream signaling. J Biol Chem 278: 50442-50448, 2003. (Pubitemid 37548889)
8. Fiegen D, Haeusler LC, Blumenstein L, et al: Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase. J Biol Chem 279: 4743-4749, 2004. (Pubitemid 38199069)
9. Radisky DC, Levy DD, Littlepage LE, et al: Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436: 123-127, 2005. (Pubitemid 40966197)
10. Goncalves V, Matos P and Jordan P: Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways. Hum Mol Genet 18: 3696-3707, 2009.
11. Matos P and Jordan P: Increased Rac1b expression sustains colo-rectal tumor cell survival. Mol Cancer Res 6: 1178-1184, 2008.
12. Matos P and Jordan P: Expression of Rac1b stimulates NF-kappaB-mediated cell survival and G1/S progression. Exp Cell Res 305: 292-299, 2005. (Pubitemid 40462541)
13. Matos P and Jordan P: Rac1, but not Rac1B, stimulates RelB-mediated gene transcription in colorectal cancer cells. J Biol Chem 281: 13724-13732, 2006. (Pubitemid 43855288)
14. Orlichenko L, Geyer R, Yanagisawa M, et al: The 19 amino acid insertion in the tumor-associated splice isoform Rac1b confers specific binding to p120 catenin. J Biol Chem (In press).
15. Matos P, Oliveira C, Velho S, et al: B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival. Gastroenterology 135: 899-906, 2008.
16. Rubinfeld B, Souza B, Albert I, et al: Association of the APC gene product with beta-catenin. Science 262: 1731-1734, 1993. (Pubitemid 24030096)
17. Su LK, Vogelstein B and Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 262: 1734-1737, 1993. (Pubitemid 24030097)
18. Miller JR: The Wnts. Genome Biol 3: Reviews3001, 2002.
19. Cadigan KM and Peifer M: Wnt signaling from development to disease: insights from model systems. Cold Spring Harb Perspect Biol 1: a002881, 2009.
20. Wodarz A and Nusse R: Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14: 59-88, 1998. (Pubitemid 29001449)
21. Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004. (Pubitemid 39488658)
22. Marikawa Y: Wnt/beta-catenin signaling and body plan formation in mouse embryos. Semin Cell Dev Biol 17: 175-184, 2006.
23. Torres MA and Nelson WJ: Colocalization and redistribution of dishevelled and actin during Wnt-induced mesenchymal morphogenesis. J Cell Biol 149: 1433-1442, 2000. (Pubitemid 30437617)
24. Itoh K, Brott BK, Bae GU, Ratcliffe MJ and Sokol SY: Nuclear localization is required for Dishevelled function in Wnt/beta-catenin signaling. J Biol 4: 3, 2005.
25. Gan XQ, Wang JY, Xi Y, Wu ZL, Li YP and Li L: Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. J Cell Biol 180: 1087-1100, 2008. (Pubitemid 351468467)
26. Esufali S, Charames GS, Pethe VV, Buongiorno P and Bapat B: Activation of tumor-specific splice variant Rac1b by dishevelled promotes canonical Wnt signaling and decreased adhesion of colorectal cancer cells. Cancer Res 67: 2469-2479, 2007. (Pubitemid 46548931)
27. Esufali S and Bapat B: Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Oncogene 23: 8260-8271, 2004. (Pubitemid 39531837)
28. Buongiorno P, Pethe VV, Charames GS, Esufali S and Bapat B: Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells. Mol Cancer 7: 73, 2008.